Related Experiment Videos
Seizure outcome in patients with surgically treated cerebral arteriovenous malformations
D G Piepgras1, T M Sundt, A T Ragoowansi
1Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota.
Abstract:
A series of 280 cases of cerebral arteriovenous malformations (AVM's) treated surgically between June, 1970, and June, 1989, is reviewed with particular focus on the preoperative seizure history and follow-up seizure status. Follow-up evaluation (mean duration 7.5 years) was achieved in 98% of cases and was accomplished through re-examinations, telephone interviews, and written questionnaires. Overall, 89% of the surviving patients with a follow-up period of greater than 2 years were free of seizures at last examination. Of the 280 patients in this series, 163 had experienced no seizures preoperatively. A recent follow-up study (with a minimum duration of 2 years or to death) was available in 157 of these 163 cases; 21 patients had died. Of the 136 surviving patients, only eight (6%) were having new ongoing seizures. In the 128 (94%) who had remained seizure-free, 73% were receiving no anticonvulsant agents while 27% were taking anticonvulsant prophylaxis. The 2-year minimum follow-up study in 110 of the 117 patients with preoperative seizures revealed that eight (7%) had died. Of the 102 surviving patients, 85 (83%) were seizure-free (with 48% no longer receiving anticonvulsant therapy), while 17 (17%) still suffered intermittent seizures. However, of these 17 patients, 13 reported their seizures to be improved compared to preoperatively; the seizures were the same in two patients and were worse in two patients. An actuarial analysis was conducted comparing the life expectancy of patients following surgery for AVM's with the expected survival of a general white population of the same age and sex in the West Northcentral region of the United States. No statistically significant difference was found. There were seven perioperative deaths (three from cerebral hemorrhage, two from pulmonary emboli, and two from obstruction of venous drainage) and 22 deaths during the follow-up period. Of these 22 deaths, the cause was unknown in four patients, apparently unrelated to the AVM in 13, and directly or indirectly related to the patient's neurological condition prior to surgery or due to surgery performed for resection of the AVM in five. There was a statistically significant relationship between the size and location of the AVM and the clinical presentation. Patients with small AVM's (< 3 cm) were more likely to present with hemorrhage whereas those with large AVM's were more likely to present with seizures.(ABSTRACT TRUNCATED AT 400 WORDS)
Insights
Surgical treatment for cerebral arteriovenous malformations (AVMs) significantly reduces seizures in most patients. Long-term follow-up shows high seizure-free rates and normal life expectancy after AVM surgery.
Area of Science:
- Neurosurgery
- Neurology
- Vascular Surgery
Background:
- Cerebral arteriovenous malformations (AVMs) are complex vascular lesions.
- Seizures are a common clinical presentation of AVMs.
- Surgical intervention is a primary treatment modality for AVMs.
Purpose of the Study:
- To evaluate the efficacy of surgical treatment for cerebral AVMs.
- To assess the impact of surgery on preoperative seizure history and follow-up seizure status.
- To compare the long-term survival rates of surgically treated AVM patients with the general population.
Main Methods:
- Retrospective review of 280 surgically treated cerebral AVM cases from 1970 to 1989.
- Long-term follow-up (mean 7.5 years) using re-examinations, telephone interviews, and questionnaires.
- Actuarial analysis comparing patient survival with the general population.
Main Results:
- 89% of surviving patients with >2 years follow-up were seizure-free.
- In patients without preoperative seizures, only 6% developed new seizures postoperatively.
- Life expectancy after AVM surgery showed no statistically significant difference compared to the general population.
Conclusions:
- Surgical resection of cerebral AVMs is highly effective in controlling seizures.
- Long-term outcomes demonstrate favorable seizure control and normal life expectancy.
- AVM size and location significantly correlate with clinical presentation (hemorrhage vs. seizures).